Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors

Published:2018-03 Issue:3 Volume:17 Page:284-289
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Lidar Merav,Giat Eitan,Garelick Daniela,Horowitz Yuval,Amital Howard,Steinberg-Silman Yael,Schachter Jacob,Shapira-Frommer Ronnie,Markel Gal

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation;Krummel;J Exp Med,1995

2. The B7 family revisited;Greenwald;Annu Rev Immunol,2005

3. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy;Khalil;Nat Rev Clin Oncol,2016

4. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

5. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08

2. Current Immunotherapy Treatments of Primary Breast Cancer Subtypes;Biomedicines;2024-04-18

3. An immune-related adverse event of Behcet’s-like syndrome following pembrolizumab treatment;BMC Pulmonary Medicine;2024-04-05

4. Morphoea and Allied Scarring and Sclerosing Inflammatory Dermatoses;Rook's Textbook of Dermatology;2024-03-19

5. Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our Practice;Medicina;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3